Philip Hemme, Author at Labiotech.eu

About

Young French-German Entrepreneur, Co-founder & CEO of Labiotech.eu. High-level table tennis player, and German beer/French Wine lover 🙂

Articles by Philip Hemme

News and Trends 3 Jul 2015

Lilly Cooperates with Immunocore to Fight Skin Cancer

Eli Lilly expands its portfolio in immune-oncology therapies. This time, Immunocore‘s lead T cell receptor-based drug, IMCgp100 is tested in combination with Lilly’s kinase inhibitors galunisertib and merestinib. This second collaboration between these two companies aims to increase drug efficacy against melanoma cancer. Melanomas are rare forms of skin cancer, that have a high potential […]

July 3, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Jul 2015

Biogen is back home with its $1Bn Swiss production plant

Biogen is coming back home. The American company is opening a production plant in Switzerland that will employ 400 professionals. To this aim, the company will invest €0.9Bn ($1Bn) into the project. Biogen was founded back in 1978 in Geneva, Switzerland, and now aims at expanding its manufacturing network by opening a biopharmaceutical plant in […]

July 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Jul 2015

Over 11500 Visitors in June!

This morning, we looked at June’s statistics and there were over 11500 visitors on Labiotech.eu last month. And look at this graph that stands on our office door, our growth is really rapid and we reached our objective. That’s just amazing, you guys ROCK! I’m really excited that we are changing the European media industry of biotech […]

July 2, 2015 - 1 minutemin - By Philip Hemme

News and Trends 30 Jun 2015

Qiagen vs. Illumina, the next Big Fight in Next-gen Sequencing

Next-gen sequencing is a revolution. San Diego-based Illumina owns most of the market but German giant Qiagen is prepared to disrupt this fact by stepping in massively by the end of the year. The fight has only begun. Imagine you could sequence your genome to discover the disease you may have in the future. What if I told you, […]

June 30, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 29 Jun 2015

6 Things the Digital Revolution already Disrupted in the Biotech Industry

2 weeks ago, I was at NOAH15 in Berlin, one of the biggest European events on Digital, gathering key opinion leaders such as Eric Schmidt from Google or Ariana Huffington, founder of the Huffington Post. They all talked about the impact of the recent digital wave, internet and the post-pc area in different industries. Biotech […]

June 29, 2015 - 6 minutesmins - By Philip Hemme

News and Trends 18 Jun 2015

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

The biggest biocluster of the World is still attractive. Munich-based Sirion Biotech decided to open an office to establish its US presence and benefit from Boston’s leading position in the gene therapy field. Gene Therapy is the next big thing in Biotech and is now moving from a theoretical dream to reality. Boston is clearly the hotspot for […]

June 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 8 Jun 2015

Review: The Emerging Field of Bioluminescence

Thanks to the synthetic biology revolution, bioluminescence is now moving from a curious natural trait to an interesting research field that could soon arrive to the market. Bioluminescence’s impulsors aim at replacing electric lighting. Sounds good, but which are the most advanced projects right now? Will bioluminescence really have an impact on the lighting market and […]

June 8, 2015 - 4 minutesmins - By Philip Hemme

News and Trends 2 Jun 2015

Will Glowee Replace Electric Lighting with Bioluminescent Bacteria?

What if we could use less electricity to light today’s civilizations? Glowee is a French start-up willing to take on this challenge by using genetically modified bacteria to produce light. I had the chance to talk with the company’s CEO Sandra Rey and will give you my thoughts. It all started from a student project in a design college. Back […]

June 2, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 1 May 2015

Addex Therapeutics: When one of the leading Swiss Biotech startups relives

Biotech startups are risky. They need lot of cash to come across the very regulated clinical path and can fail rapidly when bad results show up. Addex Therapeutics, a Swiss Geneva-based Biotech company, has raised more than €200M throughout its existence and signed deals worth more than €1Bn with Merck and J&J. Yet, on the 31st May 2013, the company almost […]

May 1, 2015 - 4 minutesmins - By Philip Hemme

final sterilization proteins solution sanofi pasteur

News and Trends 16 Apr 2015

The challenge of terminal sterilization of Proteins

The production of biologicals is an important challenge for the industry. Today, very often, the only way to have a sterile final product is to, first, use sterile components and then, launch the production in a fully aseptic manufacturing facility. What if we could terminally sterilize the protein-based outcome once produced? More and more biologicals are brought to the market, […]

April 16, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 9 Apr 2015

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

Nanomedicine could be the next revolution in healthcare and Paris-based Nanobiotix is one of the leading biotech in the field. It started from a vision in 2003 and now counts 50 employees after having raised over €70M. I had the chance to chat with Laurent Levy, founding CEO of the company, and will give you an […]

April 9, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 3 Apr 2015

The Strategic Focus of Roche-Genentech on Personal Genetic data

Personal Genetic data plays more and more a critical role in drug development. Major Pharma company Roche and its Biotech subsidiary Genentech are iconic in this trend. They have always been the first ones to catch up the wave and get profit from it. Today, Genentech believes and focus on genome sequencing to continue bringing breakthrough […]

April 3, 2015 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Philip Hemme

About

Articles by Philip Hemme

Lilly Cooperates with Immunocore to Fight Skin Cancer

Biogen is back home with its $1Bn Swiss production plant

Over 11500 Visitors in June!

Qiagen vs. Illumina, the next Big Fight in Next-gen Sequencing

6 Things the Digital Revolution already Disrupted in the Biotech Industry

German Viral Vector Producer SIRION pursues its American dream and opens in Boston

Review: The Emerging Field of Bioluminescence

Will Glowee Replace Electric Lighting with Bioluminescent Bacteria?

Addex Therapeutics: When one of the leading Swiss Biotech startups relives

The challenge of terminal sterilization of Proteins

Exclusive interview with Laurent Levy, CEO of Nanobiotix, Leading European Nanomedicine Biotech

The Strategic Focus of Roche-Genentech on Personal Genetic data

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Philip Hemme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!